Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
540.79B
Market cap540.79B
Price-Earnings ratio
20.07
Price-Earnings ratio20.07
Dividend yield
2.32%
Dividend yield2.32%
Average volume
10.93M
Average volume10.93M
High today
$225.50
High today$225.50
Low today
$220.70
Low today$220.70
Open price
$221.86
Open price$221.86
Volume
8.15M
Volume8.15M
52 Week high
$225.50
52 Week high$225.50
52 Week low
$141.50
52 Week low$141.50

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $224.44. The company's market cap stands at 540.79B, with a P/E ratio of 20.07 and a dividend yield of 2.3%.

On 2026-01-27, Johnson & Johnson(JNJ) stock traded between a low of $220.70 and a high of $225.50. Shares are currently priced at $224.44, which is +1.7% above the low and -0.5% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 8.15M, against a daily average of 10.93M.

During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $225.50 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $225.50 at its peak.

JNJ News

TipRanks 2h
J&J confirms FDA approves quadruplet regimen for multiple myeloma

Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration approved Darzalex Faspro in combination with bortezomib, lenalidomide and dex...

Nasdaq 7h
Dow Analyst Moves: JNJ

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnso...

Dow Analyst Moves: JNJ
Simply Wall St 21h
Johnson And Johnson Data Updates Reframe Oncology And Neuropsychiatry Outlook

Johnson & Johnson (NYSE:JNJ) reported positive Phase 3 MajesTEC-9 results for TECVAYLI in relapsed or refractory multiple myeloma. The company also released ne...

Johnson And Johnson Data Updates Reframe Oncology And Neuropsychiatry Outlook

Analyst ratings

52%

of 27 ratings
Buy
51.9%
Hold
40.7%
Sell
7.4%

More JNJ News

Nasdaq 1d
Johnson & Johnson a Top Ranked SAFE Dividend Stock With 2.4% Yield

Johnson & Johnson (Symbol: JNJ) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-averagestatistics including a strong...

Johnson & Johnson a Top Ranked SAFE Dividend Stock With 2.4% Yield
Simply Wall St 3d
How J&J’s 2026 Sales and EPS Outlook At Johnson & Johnson Has Changed Its Investment Story

Earlier this week, Johnson & Johnson reported fourth-quarter 2025 and full-year results showing sales of US$24.56 billion for the quarter and US$94.19 billion f...

How J&J’s 2026 Sales and EPS Outlook At Johnson & Johnson Has Changed Its Investment Story
TipRanks 4d
Top 3 Stocks to Watch Right Now, According to AI Analyst, 1/23/2026

The TipRanks AI Analyst tool scans analyst ratings, price targets, and market trends to highlight stocks with strong upside potential. Using TipRanks’ AI Analys...

24/7 Wall St. 4d
Social Security Trust Fund Will Deplete in 2032, Triggering Automatic 24% Benefit Cut Without Reform

Social Security Faces 24% Benefit Cut in 2032 Without Congressional Action Quick Read Johnson & Johnson (JNJ) and Procter & Gamble dividend growth averaged 5%...

24/7 Wall St. 4d
A 75-Year-Old Holds NVIDIA and 4 Dividend Stocks—Should He Simplify Now?

Consolidating into Schwab US Dividend Equity ETF (SCHD) or Vanguard High Dividend Yield ETF (VYM) cuts monitoring from five positions to one. NVIDIA returned 1...

A 75-Year-Old Holds NVIDIA and 4 Dividend Stocks—Should He Simplify Now?
TipRanks 4d
Johnson & Johnson price target raised to $240 from $227 at Guggenheim

Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $240 from $227 and keeps a Buy rating on the shares after the company repo...

Nasdaq 5d
Is This Dividend King a Screaming Buy?

Key Points Johnson & Johnson has increased its dividend for an impressive 63 consecutive years. The company appears to be navigating an expanding patent cliff...

Is This Dividend King a Screaming Buy?

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.